Amaero 10-Q: Going Concern Warning Despite 35% Q3 Revenue Growth
AMRO sits 80% above its 52-week low of $3.57 on light trading volume (0.3× avg).
Summary
Amaero's Q3 revenue rose 35% to $4.1 million, but a $4.4 million gross loss and $19.2 million of nine-month operating cash burn left it with $5.0 million of cash and a stated going-concern doubt, even after the $17.0 million October IPO.
Key Events · Earnings and Guidance · AMRO
-
Going Concern Doubt Stated
Management concluded that existing cash will not fund operations through the one-year look-forward period and that substantial doubt exists about the ability to continue as a going concern, even including the $17.0 million IPO net proceeds and $2.1 million of released restricted cash.
-
Q3 Gross Loss of $4.4 Million
Revenue of $4.1 million against cost of revenue of $8.5 million produced a $4.4 million gross loss, driven by the six-week titanium production pause and lower yields from the new sieving system; nine-month gross loss was $7.6 million.
-
Cash Burn and Fully Drawn EXIM Facility
Nine-month operating cash use was $19.2 million and net loss $22.5 million, leaving $5.0 million of cash and $4.7 million restricted at September 30, 2026; the $26.1 million EXIM Bank facility was fully drawn in July 2026 with no remaining capacity.
-
Runway Into Second Quarter 2027
The company states that the IPO proceeds plus existing cash fund operating expenses and capital expenditures into the second quarter of 2027, implying a further equity or debt raise is required.
Analysis · AMRO · Manufacturing
Revenue is growing fast — $4.1 million in Q3, up 35%, and $11.5 million for nine months, up 170% — but the company is losing money on every dollar of powder it ships: cost of revenue of $8.5 million produced a $4.4 million gross loss as the six-week titanium production pause and sieving-system tuning cut throughput and yields. Cash is the bigger issue. Amaero ended September with $5.0 million of cash and $4.7 million restricted, had fully drawn its $26.1 million EXIM facility by July, and burned $19.2 million in operations over nine months. Even after the $17.0 million October IPO and the $2.1 million of restricted cash released by the EXIM amendment, management states plainly that existing cash will not fund operations through the one-year look-forward period and that substantial doubt exists about going concern. The company says the money lasts into the second quarter of 2027, which means another raise — likely dilutive — is coming. Against that, backlog nearly doubled to $13.4 million, including $4.4 million from the July 2026 Department of War R&D contract, so demand is not the problem; execution and cash are.
How filings like this one have moved
In the 30 days to Nov 10, 2026, 47.7% of the 1624 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.19%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, AMRO was trading at $6.42 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $183.2M. The 52-week trading range was $3.57 to $8.64. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.